Yes, you can absolutely prescribe metformin and Lantus (insulin glargine) together for type 2 diabetes.
This combination is explicitly recommended and widely supported in current diabetes management guidelines, particularly for patients requiring insulin therapy who are already on or should be on metformin. 1, 2, 3, 4, 2
Key Guideline Recommendations
The most recent 2024 ADA Standards of Care explicitly states that metformin should be continued when used in combination with other agents, including insulin, if not contraindicated and if tolerated 1. This represents the standard of care across multiple guideline iterations 2, 3, 4, 2.
When to Use This Combination
Initiate Both Together When:
- Blood glucose ≥300 mg/dL or A1C >10% with hyperglycemic symptoms (polyuria, polydipsia) or catabolic features (weight loss, hypertriglyceridemia, ketosis) 1, 5
- In this scenario, start insulin (including Lantus) immediately while also initiating or continuing metformin
Add Lantus to Existing Metformin When:
- A1C remains ≥1.5% above individualized goal despite metformin ± other oral agents 5
- Progressive disease requiring basal insulin for glycemic control 2
Clinical Evidence Supporting This Combination
The LANMET study 6 directly demonstrated that insulin glargine combined with metformin achieved excellent glycemic control (mean HbA1c 7.14%) with reduced symptomatic hypoglycemia during the first 12 weeks compared to NPH insulin plus metformin. The combination was safe and effective across multiple clinical trials 7, 6, 8, 9.
Practical Prescribing Approach
For patients already on metformin needing insulin:
- Continue metformin at current dose (unless contraindicated)
- Start Lantus at bedtime: 10 units daily if insulin-naive, or 80% of previous NPH dose if switching 7
- Titrate Lantus to target fasting glucose 80-130 mg/dL 1
For insulin-naive patients with severe hyperglycemia:
- Start both metformin (500-850 mg daily, titrate gradually) AND Lantus (10 units at bedtime) simultaneously 2
- Once glucose toxicity resolves, you may be able to reduce or discontinue insulin 2
Critical Safety Considerations
Metformin Contraindications:
- eGFR <30 mL/min/1.73 m² is an absolute contraindication 1, 5
- Use caution with eGFR 30-45 mL/min/1.73 m² (increased lactic acidosis risk with acute kidney injury) 5
- Hold during acute illness with dehydration, nausea, or vomiting 3
Monitor for:
- Vitamin B12 deficiency - periodic testing recommended, especially with neuropathy or anemia 1, 3, 5
- Hypoglycemia risk increases when combining insulin with any oral agent, though metformin itself doesn't cause hypoglycemia 1
- Weight gain (approximately 1-2 kg expected with insulin) 6, 9
Common Pitfall to Avoid
Do NOT discontinue metformin when starting insulin unless there is a specific contraindication. This is a frequent error in clinical practice. The 2024 guidelines explicitly emphasize continuing metformin with insulin therapy 1, 5. Metformin provides complementary mechanisms (reduces hepatic glucose production, improves insulin sensitivity) that enhance the effectiveness of basal insulin 2.
FDA-Approved Indication
Lantus is FDA-approved "to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus" 7. There are no contraindications to combining it with metformin in the FDA labeling 7.
Bottom Line Algorithm
- Is eGFR ≥30? → Yes, metformin is safe
- Is patient on metformin already? → Continue it when adding Lantus
- Starting both together? → Appropriate for severe hyperglycemia (glucose ≥300 or A1C >10%)
- Dosing: Metformin 500-2000 mg daily (titrate for GI tolerance) + Lantus 10 units at bedtime (titrate to fasting glucose goal)
- Monitor: B12 levels periodically, hypoglycemia awareness, renal function
This combination represents evidence-based, guideline-concordant care for type 2 diabetes requiring insulin therapy 1, 2, 4, 5.